$2.72 -0.04 (%) Ohr Pharmaceutical Inc - NASDAQ

May. 28, 2015 | 04:00 PM

Partner Headlines

  1. Wall Street's Best and Worst Calls of the First Quarter 2015

    GuruFocus | May. 7, 2015 | 16:03PM EST
  2. Morning Market Gainers

    Benzinga | Mar. 2, 2015 | 09:45AM EST
  3. Benzinga's Top Initiations

    Benzinga | Feb. 26, 2015 | 09:13AM EST
  4. Roth Capital Initiates Ohr Pharmaceutical With Buy

    Benzinga | Feb. 26, 2015 | 08:47AM EST
  5. UPDATE: Chardan Capital Markets Initiates Coverage On OHR Pharmaceutical On Imminent OHR-102 Catalyst

    Benzinga | Feb. 2, 2015 | 10:26AM EST
  6. Ohr Pharmaceutical Announces New Positive Anatomic And Visual Acuity Data On OHR-102 IMPACT Study Presented At The 2014 American Academy Of Ophthalmology Scientific Meeting

    Benzinga | Oct. 20, 2014 | 07:31AM EST
  7. 3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus

    Benzinga | Sep. 8, 2014 | 14:25PM EST
  8. 4 Biotech Stocks With Big Money Coming In

    Benzinga | Jun. 30, 2014 | 15:50PM EST
  9. OHR Pharmaceutical Up 30%, Partly Recoups 2-Day Losing Streak

    Benzinga | Jun. 26, 2014 | 14:44PM EST
  10. OHR Pharmaceuticals Selling Off As Feuerstein Calls Phase II A Failure

    Benzinga | Jun. 24, 2014 | 13:17PM EST
  11. US Stock Futures Edge Lower Ahead Of Housing Data

    Benzinga | Jun. 24, 2014 | 07:40AM EST
  12. OHR Pharma Offers Positive Interim Top-Line Clinical Data from Phase II Study of Squalamine Eye Drops in Patients with WetAMD

    Benzinga | Jun. 24, 2014 | 07:02AM EST
  13. Mid-Day Market Movers For Monday, June 23, 2014

    Benzinga | Jun. 23, 2014 | 15:43PM EST
  14. Morning Market Losers

    Benzinga | Apr. 8, 2014 | 09:46AM EST
  15. Benzinga's Volume Movers

    Benzinga | Feb. 10, 2014 | 11:00AM EST
Trading Center